What medications can cause medication-associated lupus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications That Cause Drug-Induced Lupus

The most common medications causing drug-induced lupus are hydralazine and procainamide (high-risk), followed by isoniazid, TNF-α inhibitors, and proton pump inhibitors (moderate-risk), with hydralazine requiring immediate discontinuation if lupus develops unless the benefit-to-risk ratio necessitates continued therapy. 1, 2

High-Risk Medications

Hydralazine

  • Hydralazine is the most well-established cause of drug-induced lupus, particularly at higher doses and in slow acetylators 1, 2
  • Can produce a lupus-like syndrome that includes glomerulonephritis, which is unusual for drug-induced lupus 1, 2
  • The FDA label explicitly warns that hydralazine should be discontinued when lupus develops unless the benefit-to-risk determination requires continued therapy 2
  • Symptoms may persist for years after discontinuation and sometimes require long-term steroid therapy 1

Procainamide

  • Procainamide is associated with the highest risk of developing lupus alongside hydralazine 3, 4
  • Considered a high-risk medication in traditional drug-induced lupus 5

Isoniazid

  • Approximately 22% of patients treated with isoniazid for a mean of 6 months develop antinuclear antibodies 1, 6
  • Can present with arthralgia, fever, and pleuritis 1
  • Pericarditis occurs in approximately 30% of cases, with rare presentations including cardiac tamponade 6
  • Considered a high-risk medication for drug-induced lupus 7

Moderate-Risk Medications

TNF-α Inhibitors (Etanercept, Adalimumab, Infliximab)

  • TNF-α inhibitor-induced lupus presents differently from traditional drug-induced lupus and may include renal complications, which is atypical 1, 8
  • Patients can develop or show increases in circulating antinuclear antibodies and signs of systemic lupus erythematosus while receiving anti-TNF therapy 1
  • Anti-TNF-α DILE differs from classic DILE with higher incidence of rashes, more frequent visceral involvement including renal disease, and presence of anti-dsDNA antibodies in approximately half of cases 7
  • Anti-histone antibodies are less common with TNF-α inhibitors compared to classic drug-induced lupus 7

Proton Pump Inhibitors

  • PPIs can cause drug-induced lupus that typically presents without renal or CNS complications 8
  • The mechanism likely differs from traditional drug-induced lupus and may involve interactions with DNA or histones, rendering them immunogenic 8
  • Have been increasingly recognized as a cause of drug-induced SCLE in recent years 5

Other Implicated Medications

Lower-Risk Individual Agents

  • Chlorpromazine, methyldopa, penicillamine, quinidine, and sulfasalazine are less frequently associated 4

Drug Classes

  • Anticonvulsants as a class have been implicated 4
  • Beta-blockers as a class 4
  • Sulfonamides as a class 4
  • Calcium channel blockers (particularly for SCLE) 7
  • Angiotensin-converting enzyme inhibitors (particularly for SCLE) 7
  • Thiazide diuretics (particularly for SCLE) 7
  • Terbinafine (particularly for SCLE) 7, 5
  • Interferons (newer biological agents) 4, 7

Clinical Presentation Patterns

Traditional Drug-Induced Lupus

  • Typically presents with arthralgia/arthritis, pleurisy, rashes, and fever 1
  • Traditional drug-induced lupus rarely involves the kidneys 1
  • CNS complications are rare in classic drug-induced lupus 8

Important Caveat

Recognition can be difficult when patients are receiving medications for underlying autoimmune diseases, as symptoms may overlap with the disease being treated 7. A temporal association (months to years) with the offending drug and resolution of symptoms upon drug withdrawal provides the best evidence for diagnosis 7.

References

Guideline

Medications That Can Cause Drug-Induced Lupus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug-induced lupus.

Drug safety, 1995

Research

Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2012

Research

Drug-induced lupus erythematosus.

Archives of dermatological research, 2009

Guideline

Risk of Drug-Induced Lupus with Proton Pump Inhibitors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.